As of 2026-09-27, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (197.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -360.5%.
The range of the Relative Valuation is (189.81) - (212.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 30.8x | 28.0x |
| Forward P/E multiples | 27.5x - 33.9x | 29.5x |
| Fair Price | (189.81) - (212.14) | (197.98) |
| Upside | -349.7% - -379.1% | -360.5% |
| Date | P/E |